A Trans-Atlantic Voyage of Extended ADT With Local Radiation

This is a patient with likely>10-year life expectancy with high-volume1 (11 of 12 cores) high-risk (Gleason 8, prostate-specific antigen 30) prostate cancer, and therefore aggressive treatment with curative intent is warranted.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Source Type: research